A detailed history of Koshinski Asset Management, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Koshinski Asset Management, Inc. holds 1,312 shares of VRTX stock, worth $591,672. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,312
Previous 1,326 1.06%
Holding current value
$591,672
Previous $621,000 1.77%
% of portfolio
0.05%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$460.0 - $505.78 $6,440 - $7,080
-14 Reduced 1.06%
1,312 $610,000
Q2 2024

Jul 12, 2024

BUY
$392.81 - $485.53 $520,866 - $643,812
1,326 New
1,326 $621,000
Q4 2023

Jan 29, 2024

SELL
$343.0 - $410.68 $344,372 - $412,322
-1,004 Reduced 66.76%
500 $203,000
Q3 2023

Oct 18, 2023

SELL
$338.18 - $362.46 $18,938 - $20,297
-56 Reduced 3.59%
1,504 $523,000
Q2 2023

Jul 28, 2023

BUY
$314.42 - $351.91 $22,323 - $24,985
71 Added 4.77%
1,560 $548,000
Q1 2023

Apr 12, 2023

BUY
$283.23 - $323.1 $2,832 - $3,231
10 Added 0.68%
1,489 $469,000
Q4 2022

Jan 24, 2023

BUY
$285.76 - $321.48 $4,000 - $4,500
14 Added 0.96%
1,479 $0
Q3 2022

Oct 20, 2022

BUY
$273.83 - $305.53 $401,160 - $447,601
1,465 New
1,465 $424,000
Q2 2022

Jul 12, 2022

SELL
$234.96 - $292.55 $51,691 - $64,361
-220 Reduced 12.17%
1,587 $447,000
Q1 2022

Apr 20, 2022

SELL
$221.42 - $260.97 $89,453 - $105,431
-404 Reduced 18.27%
1,807 $472 Million
Q4 2021

Jan 14, 2022

BUY
$177.01 - $223.45 $35,579 - $44,913
201 Added 10.0%
2,211 $486 Million
Q3 2021

Oct 12, 2021

SELL
$181.39 - $202.99 $81,444 - $91,142
-449 Reduced 18.26%
2,010 $364,000
Q2 2021

Jul 26, 2021

SELL
$187.49 - $221.1 $120,743 - $142,388
-644 Reduced 20.75%
2,459 $496,000
Q1 2021

May 06, 2021

BUY
$207.02 - $241.31 $139,738 - $162,884
675 Added 27.8%
3,103 $667,000
Q4 2020

Mar 30, 2021

BUY
$207.01 - $276.09 $94,189 - $125,620
455 Added 23.06%
2,428 $574,000
Q4 2020

Feb 05, 2021

BUY
$207.01 - $276.09 $408,430 - $544,725
1,973 New
1,973 $574,000
Q4 2020

Feb 02, 2021

SELL
$207.01 - $276.09 $432,029 - $576,199
-2,087 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$255.65 - $303.1 $61,611 - $73,047
-241 Reduced 10.35%
2,087 $573,000
Q2 2020

Jul 29, 2020

BUY
$225.48 - $295.8 $198,196 - $260,008
879 Added 60.66%
2,328 $676,000
Q1 2020

Apr 30, 2020

BUY
$199.77 - $247.81 $9,389 - $11,647
47 Added 3.35%
1,449 $345,000
Q4 2019

Jan 29, 2020

BUY
$166.71 - $223.91 $233,727 - $313,921
1,402 New
1,402 $307,000
Q1 2019

May 14, 2019

SELL
$163.73 - $194.7 $472,688 - $562,098
-2,887 Closed
0 $0
Q4 2018

Feb 08, 2019

SELL
$151.91 - $192.21 $166,341 - $210,469
-1,095 Reduced 27.5%
2,887 $478,000
Q3 2018

Nov 15, 2018

SELL
$167.73 - $192.74 $679,306 - $780,597
-4,050 Reduced 50.42%
3,982 $767,000
Q2 2018

Aug 10, 2018

SELL
$145.72 - $169.96 $5,828 - $6,798
-40 Reduced 0.5%
8,032 $572,000
Q1 2018

Apr 09, 2018

BUY
$151.6 - $177.13 $1.22 Million - $1.43 Million
8,072 New
8,072 $1.32 Million
Q3 2017

Oct 12, 2017

SELL
$148.13 - $162.24 $253,154 - $277,268
-1,709 Closed
0 $0
Q2 2017

Jan 17, 2018

BUY
N/A
1,709
1,709 $220,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Koshinski Asset Management, Inc. Portfolio

Follow Koshinski Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Koshinski Asset Management, Inc. with notifications on news.